Journal of the American College of Cardiology © 2007 by the American College of Cardiology Foundation Published by Elsevier Inc.
Vol. 49, No. 23, 2007 ISSN 0735-1097/07/$32.00 doi:10.1016/j.jacc.2007.03.026
Coronary Artery Disease
Correlation Between Morphologic Characteristics and Local Temperature Differences in Culprit Lesions of Patients With Symptomatic Coronary Artery Disease Konstantinos Toutouzas, MD, Andreas Synetos, MD, Elli Stefanadi, MD, Sophia Vaina, MD, Virginia Markou, MD, Manolis Vavuranakis, MD, FACC, Eleftherios Tsiamis, MD, Dimitrios Tousoulis, MD, FACC, Christodoulos Stefanadis, MD, FACC Athens, Greece Objectives
The purpose of this study was to investigate the possible correlation between morphologic and functional characteristics of culprit lesions (CL) in patients with acute coronary syndromes (ACS) and chronic stable angina (CSA).
Background
Intravascular ultrasound (IVUS) provides morphologic assessment and intracoronary thermography (ICT) evaluates the local inflammatory activation of CL.
Methods
Eighty-one consecutive patients, 48 with ACS and 33 with CSA, were enrolled. Ratio of lesion to reference external elastic membrane area, indicated by IVUS, was defined as positive remodeling index (pRi) (ⱖ1) or negative remodeling index (nRi) (⬍1). We also investigated the existence of ruptured plaque (rp) in the CL. By ICT temperature difference (⌬T) between the CL and the proximal vessel wall was measured.
Results
Patients with ACS had greater remodeling index than patients with CSA (1.15 ⫾ 0.18 vs. 0.90 ⫾ 0.12; p ⬍ 0.01), as well as increased ⌬T (0.08 ⫾ 0.03°C vs. 0.04 ⫾ 0.02°C; p ⬍ 0.01). Patients with pRi had higher ⌬T than patients with nRi (0.07 ⫾ 0.03°C vs. 0.04 ⫾ 0.02°C; p ⬍ 0.001). In patients with nRi there was no difference in ⌬T between ACS and CSA (p ⫽ 0.22). Patients with rp had increased ⌬T compared with patients without rp (0.09 ⫾ 0.03°C vs. 0.05 ⫾ 0.02°C; p ⬍ 0.01). Multivariate analysis showed that ⌬T was independently correlated with the presence of rp, pRi, and ACS.
Conclusions
The present study showed that culprit lesions with plaque rupture and positive arterial remodeling have increased thermal heterogeneity, although in certain patients a discrepancy between morphogic and functional characteristics was observed. A combination of morphologic and functional examination may offer additional diagnostic and prognostic information. (J Am Coll Cardiol 2007;49:2264–71) © 2007 by the American College of Cardiology Foundation
Intravascular ultrasound (IVUS) studies demonstrated that culprit lesions of patients with acute coronary syndromes (ACS) have distinct morphologic characteristics. CompenSee page 2272
satory enlargement of arterial dimensions at the site of lesions compared with the reference segments is a recognized response to optimize shear stress and wall tension as an attempt to overcome flow-limiting stenosis by preserving an adequate lumen (1). Remodeling index (Ri) was shown
From the First Department of Cardiology, Hippokration Hospital, University of Athens, Greece. Manuscript received November 20, 2006; revised manuscript received January 29, 2007, accepted March 6, 2007.
to be significantly higher in patients suffering from ACS than in patients with chronic stable angina (CSA) (2,3). Moreover, in patients with ACS an increased number of ruptured plaques is observed compared with patients with CSA (4,5). Certain risk factors have been related to vascular remodeling. Decreased adaptive or even constrictive remodeling has been related to hypertension (6,7), decreased highdensity lipoprotein levels (7), age (8,9), and insulin-treated diabetes mellitus (10,11). In contrast, insulin resistance in nondiabetics is associated with expansive remodeling (12). Interestingly, a constrictive arterial wall remodeling is observed during plaque-stabilizing therapy with statin medications (13). Studies of human autopsy specimens investigated the correlation between local inflammatory activation with ar-
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
terial remodeling. Indeed, increased lipid core size, calcium, macrophage, and matrix metalloproteinases content were associated with expansive arterial remodeling (14 –16). Animal studies have confirmed this to be mediated through interleukin-6 (17), matrix metalloproteinases (18), and P-selectin (19,20). Furthermore, human systemic inflammatory mediators, such as C-reactive protein, interleukin-6, soluble vascular and intercellular adhesion molecules 1, are related to culprit artery plaque size and arterial remodeling (21,22). However, there are no in vivo human studies correlating the local temperature with the morphologic characteristics, including arterial remodeling and plaque rupture. Both experimental and human studies demonstrated that plaque temperature is correlated with increased macrophage content (23–25), as well as systemic inflammatory indexes (26,27). Thus, intracoronary thermography (ICT) provides in vivo evidence of local inflammatory activation in coronary lesions (28). The aim of the present study was to investigate a possible correlation between certain morphologic characteristics and observed temperature of culprit lesions in patients with symptomatic coronary artery disease (CAD) suffering from CSA or ACS.
Methods Study population. We prospectively enrolled 81 consecutive patients, scheduled for percutaneous coronary intervention: 48 suffering from ACS and 33 from CSA. Angiographic inclusion criteria were: 1-vessel disease with a single significant lesion ⬃20 mm in length and proximal reference vessel diameter ⱖ2.5 mm. Patients with multivessel CAD of inflammatory or neoplastic condition were excluded from the study, as were patients treated with corticosteroids or nonsteroidal antiinflammatory drugs, except for aspirin. The institutional ethics committee approved the study protocol, and each patient provided written informed consent. Chronic stable angina was defined as angina without change in frequency, duration, or intensity of symptoms over the last 6 weeks before the study. In patients with CSA, ischemia had to be documented with noninvasive techniques. Patients suffering from unstable angina, defined as new onset of severe angina, accelerated angina, or angina at rest, were included in the ACS group. Patients with recent myocardial infarction (⬍1 month) were not included in the study. ICT catheter. The technical characteristics of the thermistor and the data acquisition and processing system have been previously described (29 –31). Briefly, the coronary thermography catheter contains 2 lumens: The first runs through the distal 20 cm of the device and is used for insertion of a guidewire (0.014-inch), which is advanced by a monorail system. The thermistor is positioned at the distal part of the thermography catheter. The ICT catheter used
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
was 3-, 3.5-, or 4-F in diameter, depending on the size of the vessel. IVUS imaging. The IVUS catheter (Volcano Corp., Rancho Cordova, California) has a synthetic aperture array electronic transducer design with a 20MHz operating frequency. The images were stored on a compact disc for later review. Electrocardiographic tracings were continuously displayed on the console screen during the study. Procedure. All patients underwent quantitative coronary angiography. The lesion of interest was well delineated in 2 views, on which the positioning of the catheters was based.
2265
Abbreviations and Acronyms ACS ⴝ acute coronary syndromes CAD ⴝ coronary artery disease CSA ⴝ chronic stable angina EEMA ⴝ external elastic membrane area ICT ⴝ intracoronary thermography IVUS ⴝ intravascular ultrasound LA ⴝ lumen area nRi ⴝ negative remodeling index PA ⴝ plaque area pRi ⴝ positive remodeling index Ri ⴝ remodeling index
The IVUS rp ⴝ ruptured plaque imaging catheter was inserted ⌬T ⴝ temperature and advanced along the guidedifference wire as distally as possible, using fluoroscopic guidance. With automatic pullback (0.5 mm/s), ultrasound images were obtained and recorded for quantitative data analysis.
IVUS EXAMINATION.
Five minutes after the last injection of contrast medium, the ICT catheter was advanced through the guidewire. Baseline temperature was obtained when the thermistor had just emerged from the tip of the guiding catheter without being in contact with the vessel wall. Thereafter, temperature was recorded at the proximal nondiseased segment and at the atherosclerotic lesions, being confirmed by IVUS (26,32,33). The fluoroscopic images of target lesion and proximal nondiseased segment were frozen during IVUS catheter pullback and guided the ICT procedure. Temperature difference (⌬T) was calculated by subtracting the mean temperature of proximal vessel wall from the maximal temperature at the lesion site. Afterward, percutaneous coronary intervention was performed. IVUS analysis. After the procedure, off-line analysis of the recorded images was performed blinded to the clinical characteristics and the temperature measurements by experienced investigators. Quantitative measurements were obtained from the frames at the end-diastolic phase. Crosssectional ultrasound measurements were performed at the lesion site, which was the image slice with the smallest lumen area (LA); if there were several image slices with an equally small lumen, the one with the largest external elastic membrane area (EEMA) and plaque area (PA) was analyzed. Cross-sectional ultrasound images in proximal healthy reference segments within 10 mm but before any major side branch were also measured. The PA was calculated as EEMA minus LA. Stenosis (%) was calculated as ICT PROCEDURE.
2266
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
Baseline Characteristics Table 1
Baseline Characteristics ACS (n ⴝ 48)
CSA (n ⴝ 33)
61.13 ⫾ 10.14
62.30 ⫾ 8.49
0.52
Gender (male)
43 (89.6%)
31 (93.9%)
0.69
Hypertension
30 (62.5%)
19 (57.6%)
0.81
6 (12.5%)
7 (21.2%)
0.36
Hypercholesterolemia
34 (70.8%)
25 (75.8%)
0.99
Smoking
28 (58.3%)
18 (54.5%)
0.82
Family history of CAD
20 (41.7%)
7 (21.2%)
0.07
Nitrates
21 (43.8%)
14 (42.4%)
0.99
Aspirin
26 (54.2%)
20 (60.6%)
0.65
ACE inhibitors
12 (25.0%)
7 (21.2%)
0.79
Age (yrs)
Diabetes mellitus
p Value
Statins
11 (22.9%)
8 (24.2%)
0.99
Calcium-channel blockers
10 (20.8%)
7 (21.2%)
0.99
Beta-blockers
17 (35.4%)
13 (39.4%)
0.81
LAD
19 (39.6%)
13 (39.4%)
0.44
LCx
14 (29.2%)
6 (18.2%)
RCA
15 (31.2%)
14 (42.4%)
Proximal
20 (41.7%)
18 (54.5%)
Middle
17 (35.4%)
10 (30.3%)
Distal
11 (22.9%)
9 (27.3%)
Target vessel
Location 0.70
ACE ⫽ angiotensin converting enzyme; ACS ⫽ acute coronary syndromes; CAD ⫽ coronary artery disease; CSA ⫽ chronic stable angina; LAD ⫽ left anterior descending coronary artery; LCx ⫽ left circumflex coronary artery; RCA ⫽ right coronary artery.
the ratio of PA to EEMA. Remodeling index was defined as the ratio of EEMAL (lesion) to EEMAR (reference). Two patterns of Ri were recognized: positive remodeling index (pRi) and negative remodeling index (nRi) were defined as indices of ⱖ1 and ⬍1, respectively. We assigned plaques as ruptured when containing a cavity communicating with the lumen via an overlying residual fibrous cap fragment. A fissure without a cavity communicating with the true lumen was not included in the analysis. Rupture sites separated by a length of artery containing a smooth lumen contour and no cavity were considered to represent different plaque ruptures (4,5). Statistical analysis. Continuous variables are presented as mean ⫾ standard deviation, and categoric variables are presented as absolute and relative frequencies. The presented figures show median values and interquartile range owing to the skewed distribution of ⌬T. Comparisons of ⌬T between groups of study were performed with nonparametric statistical methods (Mann-Whitney criterion) owing to the small sample and the skewed distribution of the investigated indices. Categoric variables were compared using the chi-square test and continuous variables using the Mann-Whitney test (independent comparison). Correlations between temperature and IVUS measurements were evaluated by the use of Spearman correlation coefficient. The effect of the interaction between Ri and clinical syndrome on log-transformed temperature differences was tested by the application of the analysis of covariance. The correlation of ⌬T, as a continuous variable, with all variables was tested by linear multiple regression analysis. A stepwise backward elimination procedure evaluated the associ-
ation between ⌬T and age, gender, smoking, hypertension, hypercholesterolemia, diabetes mellitus, family history of coronary artery disease, plaque rupture, Ri, use of statins, and clinical syndrome. The cut-off for the p value for entering a variable in the model was set to 0.05, and the cut-off for removing a variable from the model was 0.10. Results from multiple regression analysis are presented as standardized beta coefficients. All reported p values are exact, based on 2-sided tests and compared with a significance level of 5%. Stata 6 software was used for the calculations (Stata Corp., College Station, Texas). Results There were no significant differences between the 2 groups regarding the baseline demographic and angiographic characteristics (Table 1). Similar percentages of patients were receiving aspirin, angiotensin-converting enzyme inhibitors, nitrates, beta-blockers, calcium-channel blockers, and statins in each group. Ten patients (21%) with ACS had non–ST-segment elevation myocardial infarction. IVUS measurements. At the proximal reference site, there was no significant difference between CSA and ACS groups in EEMAR, PA, LA, or stenosis (Table 2). Similarly, at the lesion site there was no significant difference between CSA and ACS groups in EEMAL, PA, LA, or stenosis. The Ri was significantly greater in ACS than in CSA (1.15 ⫾ 0.18 vs. 0.90 ⫾ 0.11; p ⬍ 0.01) (Fig. 1). Positive Ri was more common in ACS (37.77% vs. 10.30%; p ⬍ 0.01) and in lesions located in the left anterior descending artery. We also categorized the study population according to Ri: 47 patients with pRi and 34 with nRi. There were no differences between these groups according to the baseline demographic and angiographic characteristics (Table 3). At the proximal reference site, there was no significant difference between both Ri groups with respect to stenosis (%), EEMAR, LA, and PA. At the lesion site, stenosis was similar between the 2 groups, and EEMAL and PA were significantly lower in the nRi group (Table 4). IVUS Measurements Table 2
IVUS Measurements ACS (n ⴝ 48)
CSA (n ⴝ 33)
p Value
Reference 14.95 ⫾ 4.77
15.07 ⫾ 3.43
0.89
Lumen reference area (mm2)
9.07 ⫾ 3.19
9.48 ⫾ 2.69
0.55
Plaque reference area (mm2)
5.87 ⫾ 2.26
5.60 ⫾ 1.43
0.54
39.09 ⫾ 7.51
37.44 ⫾ 7.37
0.33 ⬍0.01
EEMAR (mm2)
Stenosis (%) Lesion
16.86 ⫾ 4.86
13.42 ⫾ 3.63
Lumen lesion area (mm2)
5.70 ⫾ 2.44
4.36 ⫾ 1.94
0.01
Plaque lesion area (mm2)
11.17 ⫾ 3.80
9.06 ⫾ 2.51
⬍0.01
Stenosis (%)
66.01 ⫾ 10.26
67.86 ⫾ 9.12
0.41
1.15 ⫾ 0.18
0.90 ⫾ 0.12
⬍0.01
EEMAL (mm2)
Remodeling index
EEMAL ⫽ lesion external elastic membrane area; EEMAR ⫽ reference external elastic membrane area; other abbreviations as in Table 1.
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
2267
Baseline Characteristics Stratified by the Remodeling Index Table 3
Baseline Characteristics Stratified by the Remodeling Index Positive Remodeling (n ⴝ 47)
Negative Remodeling (n ⴝ 34)
60.92 ⫾ 9.39
62.56 ⫾ 9.64
0.45
Gender (male)
45 (95.7%)
29 (85.3%)
0.69
Hypertension
30 (63.8%)
19 (55.9%)
0.49
8 (17.0%)
5 (14.7%)
0.99
35 (74.5%)
24 (70.6%)
0.80
Smoking
23 (48.9%)
23 (67.6%)
0.11
Family history of CAD
19 (40.4%)
7 (20.6%)
0.09
Nitrates
19 (40.4%)
16 (47.1%)
0.65
Aspirin
28 (59.6%)
18 (52.9%)
0.65
ACE inhibitors
13 (27.7%)
6 (17.6%)
0.42
Statins
12 (25.5%)
7 (20.6%)
0.79
Calcium-channel blockers
12 (25.5%)
5 (14.7%)
0.28
Beta-blockers
20 (42.6%)
10 (29.4%)
0.25
LAD
22 (46.8%)
10 (29.4%)
0.03
LCx
14 (29.8%)
6 (17.7%)
RCA
11 (23.4%)
18 (52.9%)
Proximal
23 (48.9%)
15 (44.1%)
Middle
15 (31.9%)
12 (35.3%)
Distal
9 (19.2%)
7 (20.6%)
Age (yrs)
Diabetes mellitus Hypercholesterolemia
p Value
Target vessel
Location 0.91
Abbreviations as in Table 1.
Temperature measurements. Baseline temperature measurements were constant in each patient, varying by only 0.02°C, with a standard deviation of 0°C to 0.03°C. Patients with ACS had higher ⌬T compared with CSA (0.08 ⫾ 0.03°C vs. 0.04 ⫾ 0.02°C; p ⬍ 0.01) (Fig. 2). Patients with pRi had increased ⌬T compared with those with nRi (0.07 ⫾ 0.03°C vs. 0.04 ⫾ 0.02°C; p ⬍ 0.01) (Fig. 2). Among patients with ACS, pRi showed higher ⌬T than nRi (p ⬍ 0.01), whereas no statistical significance was achieved among patients with CSA (p ⫽ 0.53) (Fig. 3, Table 5). Patients with pRi suffering from ACS had higher ⌬T than those with CSA (p ⬍ 0.01). In patients with nRi there was no difference in ⌬T between ACS and CSA (p ⫽ 0.22) (Table 5). A good correlation was found between ⌬T and Ri (p ⬍ 0.01; r ⫽ 0.59) (Fig. 4).
Ruptured plaques. Plaque rupture was more frequently observed in patients with ACS (n ⫽ 39.6%) than in patients with CSA (n ⫽ 15.2%; p ⫽ 0.01). Ruptured plaques had increased ⌬T compared with nonruptured (0.09 ⫾ 0.03°C vs. 0.05 ⫾ 0.02°C; p ⬍ 0.01). Among patients with CSA, those with ruptured plaque had higher ⌬T than those without (p ⬍ 0.01). In the subgroups of patients with ruptured and nonruptured plaques, ⌬T was increased in the presence of ACS compared to CSA (p ⬍ 0.01) (Table 6, Fig. 5). After multiple regression analysis, ⌬T was significantly associated with the presence of ruptured plaque ( ⫽ 0.48; p ⬍ 0.001), positive remodeling ( ⫽ 0.18; p ⫽ 0.03), and presence of ACS ( ⫽ 0.34; p ⬍ 0.001). Moreover, regarding the other variables entered in the initial model, ⌬T was borderline associated with age ( ⫽ ⫺0.19; p ⫽ 0.03) and male gender ( ⫽ ⫺0.16; p ⫽ 0.08).
IVUS Measurements Stratified by the Remodeling Index Table 4
IVUS Measurements Stratified by the Remodeling Index Positive Remodeling (n ⴝ 47)
Negative Remodeling (n ⴝ 34)
p Value
Reference 14.44 ⫾ 4.63
15.77 ⫾ 3.59
0.17
Lumen reference area (mm2)
8.72 ⫾ 3.14
9.96 ⫾ 2.63
0.07
Plaque reference area (mm2)
5.72 ⫾ 2.20
5.82 ⫾ 1.58
0.83
39.49 ⫾ 7.72
36.94 ⫾ 6.90
0.13
16.72 ⫾ 4.97
13.72 ⫾ 3.69
0.004
5.68 ⫾ 2.69
4.43 ⫾ 1.46
0.02
EEMAR (mm2)
Stenosis (%) Lesion EEMAL (mm2) Lumen lesion area (mm2) Plaque lesion area (mm2)
11.04 ⫾ 3.38
9.30 ⫾ 3.40
0.03
Stenosis (%)
66.53 ⫾ 10.02
67.09 ⫾ 9.62
0.80
Abbreviations as in Table 2.
2268
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
Figure 3
Figure 1
⌬T in Lesions With Negative and Positive Remodeling
Difference between atherosclerotic plaque temperature and background temperature (⌬T) in patients with negative remodeling and those with positive remodeling. The bottom of each box represents the first quartile, the top of the box represents the third quartile, and the line in the box represents the median value of ⌬T.
Discussion The results of the present study demonstrate that certain morphologic characteristics of culprit lesions are correlated with local plaque temperature measurements. Specifically, arterial remodeling and plaque rupture are independent predictors of ⌬T. We also confirmed previously reported impact of clinical syndrome in local temperature measurements (30,34,35). Moreover, we observed that in patients suffering from CSA there is no difference in ⌬T between lesions with positive and negative Ri.
Temperature Measurements Stratified by Clinical Syndrome and Remodeling Index
The ⌬T stratified by clinical syndrome and remodeling index. The bottom of each box represents the first quartile; the top of the box represents the third quartile, and the line in the box represents the median value of ⌬T. Abbreviations as in Figure 1.
Several factors have been found to be associated with positive arterial remodeling, primarily, the clinical syndrome, because positive remodeling is found more frequently in patients with ACS and negative remodeling in patients with CSA (3). Several variables affect the process of remodeling, including hypertension (6,7), hypercholesterolemia (7), age (8,9), diabetes mellitus (10,11), and statin treatment (13). In the present study, after stratification of the population by the clinical syndrome, all of the mentioned variables were similar between the compared groups. A significant correlation between inflammation and arterial remodeling has been recognized in several autopsy and animal studies. Enhanced macrophage infiltration in human atheromatic plaques is associated with positive arterial remodeling (14 –16). Experimental animal studies showed this to be mediated through inflammatory indexes including interleukin-6 (17), matrix metalloproteinases (18), and P-selectin (19,20). In vivo human studies, however, have not investigated this correlation, except for recent studies exploring the linkage between systemic C-reactive protein and arterial remodeling at the culprit lesions of patients with acute myocardial infarction (21,22). Local inflammatory activation was evaluated by ICT, because that is the only method currently available that can be used in vivo to measure heat generation from atheromatic plaques indicating local inflammation (28). Previous ex vivo Temperature by Remodeling Difference Index andStratified Type of Syndrome Temperature Difference Stratified Table 5 by Remodeling Index and Type of Syndrome
Figure 2
⌬T in Patients With ACS and CSA
Difference between atherosclerotic plaque temperature and background temperature (⌬T) in patients with acute coronary syndromes (ACS) and those with chronic stable angina (CSA). The bottom of each box represents the first quartile, the top of the box represents the third quartile, and the line in the box represents the median value of ⌬T.
Positive Remodeling (n ⴝ 47)
Negative Remodeling (n ⴝ 34)
p Value
ACS (n ⫽ 48)
0.08 ⫾ 0.03°C (n ⫽ 37)
0.05 ⫾ 0.03°C (n ⫽ 11)
0.01
CSA (n ⫽ 33)
0.04 ⫾ 0.02°C (n ⫽ 10)
0.03 ⫾ 0.01°C (n ⫽ 23)
0.53
⬍0.01
0.22
p value Abbreviations as in Table 1.
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
Figure 5
Figure 4
⌬T in Nonruptured and Ruptured Plaques
The presence of ruptured plaque is associated with increased ⌬T both in patients with ACS and in those with CSA (p ⬍ 0.01). The bottom of each box represents the first quartile, the top of the box represents the third quartile, and the line in the box represents the median value of ⌬T. Abbreviations as in Figures 1 and 2.
Correlation of ⌬T and Ri
Remodeling index (Ri) is positively correlated with the difference between atherosclerotic plaque temperature and background temperature (⌬T) (p ⬍ 0.01; r ⫽ 0.59).
and in vivo studies have shown that plaque temperature reflects the pathologic substrate of the lesion (23–25,36,37) and moreover is correlated with systemic inflammatory indexes (26,30). Inflamed plaques, with greater percentage of macrophages, have higher thermal heterogeneity. The results of the present study confirmed the correlation between increased functional characteristics, adaptive arterial compensatory enlargement, and distinct morphologic characteristics of the culprit lesion. This is clearly demonstrated, first, by the correlation of remodeling index with ⌬T, second, by the increased ⌬T of ruptured plaques, and, finally, by the results of the multivariate analysis, which indicated the independent correlation between the 2 latter variables and ⌬T. In the multivariate analysis we did not confirm previous observations regarding the effect of statins on ⌬T, possibly owing to the small number of patients receiving statins in the present study. We did not correlate other qualitative characteristics of the atheromatic plaques with ⌬T, because the sensitivity of IVUS for tissue characterization, known to be related to plaque vulnerability, seems to be limited compared with other new invasive methods. The results of the present study justify the design of a study for the investigation of a possible correlation between temperature measurements and qualitative plaque characteristics evaluated by optical coherence tomography, which has an increased resolution even for quantification of
macrophage concentration in the cap of atherosclerotic lesions (38). It should be emphasized, however, that in certain patients a discrepancy was detected between the morphologic characteristics and plaque temperature. Interestingly, in patients with CSA ⌬T was similar between patients with positive and negative Ri. This discrepancy was also found in patients with nRi, in which ⌬T was similar between ACS and CSA groups. These observations suggest that local inflammatory activation, as detected by ICT, is not the only pathophysiologic substrate involved in ACS and positive remodeling, and the specific morphologic characteristics, as detected by IVUS, may not reveal all “high-risk” plaques. Therefore, the combined use of ICT measurements and pRi for the identification of vulnerable plaques warrants further investigation. Clinical implications. Previous studies have shown that arterial remodeling (39) and thermal heterogeneity (35) are prognostic factors for long-term outcome after percutaneous coronary interventions. The combination of both morphologic and functional characteristics may provide more accurate risk stratification after percutaneous coronary intervention, especially in the era of drug-eluting stents. Patients with negative remodeling and lower thermal heterogeneity may have lower risk for an event. Especially for patients presenting with ACS, the role of plaque erosion and not rupture should be further investigated, because erosion is
Temperature Difference Stratified by Plaque Rupture and Type of Syndrome Table 6
Temperature Difference Stratified by Plaque Rupture and Type of Syndrome ACS (n ⴝ 48)
CSA (n ⴝ 33)
Ruptured (n ⫽ 24)
0.10 ⫾ 0.03°C (n ⫽ 19)
0.06 ⫾ 0.02°C (n ⫽ 5)
⬍0.01
Nonruptured (n ⫽ 57)
0.06 ⫾ 0.03°C (n ⫽ 29)
0.03 ⫾ 0.02°C (n ⫽ 28)
⬍0.01
⬍0.01
⬍0.01
p value Abbreviations as in Table 1.
2269
p Value
2270
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
implicated in a minority of patients with ACS. In contrast, patients suffering from ACS with increased heat production and positive remodeling may require an aggressive interventional and pharmaceutic treatment. All these issues need to be clarified in a prospective study. Study limitations. We included only patients with 1-vessel disease and significant stenosis, as confirmed by IVUS, at the culprit lesions. A minimal lumen area of 5.7 mm2 was found in ACS, possibly owing to the positive remodeling observed in these patients, although the stenosis was similar to that in the CSA group. Significant lesions were studied to avoid the “cooling effect” of blood flow on plaque temperature measurements (31,40) and to ensure contact of the thermistor to the target lesion. Moreover, differentdiameter coronary thermography catheters were used, depending on the diameter of the target coronary artery. We therefore cannot extrapolate the present results to intermediate lesions and patients with multivessel disease. Furthermore, there was no difference in stenosis between the ACS and CSA groups. Therefore, the difference observed in ⌬T between the 2 groups confirmed previous observations (29,30) and cannot be attributed to the “cooling effect” of blood flow. Earlier studies (5,41) have demonstrated that patients with ACS have diffuse vulnerability and multiple plaque ruptures even proximal to the target lesion. Although proximal ruptured sites would only underestimate the present results, because the temperature of the proximal vessel wall would be increased, we included patients with distinct lesions, and the proximal vessel wall was free of rupture as evaluated by IVUS. Another known factor influencing thermal heterogeneity is the administration of statins (26,33,42). We did not find an effect of statins on ⌬T, because, first, a limited number of patients were under statin therapy in the whole study group and, second, the percentage of treated patients was similar between the studied groups. Finally, these findings were observed only in culprit lesions producing significant stenosis. Whether this correlation between certain morphologic and functional characteristics is also found in nonculprit lesions needs further investigation.
Conclusions We revealed a correlation between atheromatous plaque distinct morphologic and functional characteristics assessed by IVUS and coronary thermography, respectively. In certain patients, however, a discrepancy between temperature measurements and morphology was observed. Whether the combination of morphologic and functional examination of atheromatous plaques will offer additional information for the identification of “high-risk” plaques and for the risk stratification of coronary heart disease needs to be further investigated.
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71
Reprint requests and correspondence: Dr. Konstantinos Toutouzas, 26 Karaoli and Dimitriou str., Holargos, 15562 Athens, Greece. E-mail:
[email protected].
REFERENCES
1. Nishioka T, Luo H, Eigler NL, Berglund H, Kim CJ, Siegel RJ. Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J Am Coll Cardiol 1996;27:1571– 6. 2. Iwami T, Nishioka T, Fishbein MC, et al. Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris—an intravascular ultrasound study. Clin Cardiol 2003;26:384 –9. 3. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000;101:598 – 603. 4. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904 –10. 5. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804 – 8. 6. Isoda K, Arakawa K, Kamezawa Y, et al. Effect of coronary risk factors on arterial compensatory enlargement in Japanese middle-aged patients with de novo single-vessel disease—an intravascular ultrasound study. Clin Cardiol 2001;24:443–50. 7. Britten MB, Zeiher AM, Schachinger V. Effects of cardiovascular risk factors on coronary artery remodeling in patients with mild atherosclerosis. Coron Artery Dis 2003;14:415–22. 8. Ishida S, Hamasaki S, Kamekou M, et al. Advancing age is associated with diminished vascular remodeling and impaired vasodilation in resistance coronary arteries. Coron Artery Dis 2003;14:443–9. 9. Gyongyosi M, Yang P, Hassan A, et al. Coronary risk factors influence plaque morphology in patients with unstable angina. Coron Artery Dis 1999;10:211–9. 10. Kornowski R, Mintz GS, Lansky AJ, et al. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 1998;81:1298 –304. 11. Reddy HK, Koshy SK, Wasson S, et al. Adaptive-outward and maladaptive-inward arterial remodeling measured by intravascular ultrasound in hyperhomocysteinemia and diabetes. J Cardiovasc Pharmacol Ther 2006;11:65–76. 12. Yoshitama T, Nakamura M, Tsunoda T, et al. Insulin resistance in nondiabetic patients is associated with expansive remodeling in coronary arterial lesions. Coron Artery Dis 2004;15:187–93. 13. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006;113:2826 –34. 14. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105:297–303. 15. Pasterkamp G, Schoneveld AH, Hijnen DJ, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000;150:245–53. 16. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002;105: 939 – 43. 17. Schieffer B, Selle T, Hilfiker A, et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004;110:3493–500. 18. Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999;85:1179 – 85. 19. Hayashi S, Watanabe N, Nakazawa K, et al. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation 2000;102:1710 –7.
JACC Vol. 49, No. 23, 2007 June 12, 2007:2264–71 20. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Remodeling and neointimal formation in the carotid artery of normal and P-selectin– deficient mice. Circulation 1997;96:4333– 42. 21. Suzuki M, Inaba S, Nagai T, Tatsuno H, Kazatani Y. Relation of C-reactive protein and interleukin-6 to culprit coronary artery plaque size in patients with acute myocardial infarction. Am J Cardiol 2003;91:331–3. 22. Worthley SG, Farouque HM, Cameron JD, Meredith IT. Arterial remodeling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectoris. J Invasive Cardiol 2006;18:28 –31. 23. Verheye S, De Meyer GR, Van Langenhove G, Knaapen MW, Kockx MM. In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 2002;105:1596 – 601. 24. Madjid M, Naghavi M, Malik BA, Litovsky S, Willerson JT, Casscells W. Thermal detection of vulnerable plaque. Am J Cardiol 2002;90: 36L–9L. 25. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996;347:1447–51. 26. Stefanadis C, Toutouzas K, Tsiamis E, et al. Relation between local temperature and C-reactive protein levels in patients with coronary artery disease: effects of atorvastatin treatment. Atherosclerosis 2006 July 3;[E-pub ahead of print]. 27. Toutouzas K, Drakopoulou M, Markou V, et al. Correlation of systemic inflammation with local inflammatory activity in nonculprit lesions: beneficial effect of statins. Int J Cardiol 2007 Jan 25;[E-pub ahead of print]. 28. Madjid M, Willerson JT, Casscells SW. Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol 2006;47:C80 –5. 29. Toutouzas K, Drakopoulou M, Mitropoulos J, et al. Elevated plaque temperature in nonculprit de novo atheromatous lesions of patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:301– 6. 30. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999;99:1965–71. 31. Stefanadis C, Toutouzas K, Tsiamis E, et al. Thermal heterogeneity in stable human coronary atherosclerotic plaques is underestimated in vivo: the “cooling effect” of blood flow. J Am Coll Cardiol 2003;41: 403– 8.
Toutouzas et al. Temperature and Remodeling of Culprit Lesions
2271
32. Toutouzas K, Markou V, Drakopoulou M, et al. Increased heat generation from atherosclerotic plaques in patients with type 2 diabetes: an increased local inflammatory activation. Diabetes Care 2005;28:1656 – 61. 33. Stefanadis C, Toutouzas K, Vavuranakis M, et al. Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J 2002;23:1664 –9. 34. Leborgne L, Dascotte O, Jarry G, et al. Multi-vessel coronary plaque temperature heterogeneity in patients with acute coronary syndromes. First study with the Radi Medical System wire (abstr). Circulation 2005;112. 35. Stefanadis C, Toutouzas K, Tsiamis E, et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001;37:1277– 83. 36. Krams R, Verheye S, van Damme LC, et al. In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity. Eur Heart J 2005;26:2200 –5. 37. Toutouzas K, Spanos V, Ribichini F, et al. A correlation of coronary plaque temperature with inflammatory markers obtained from atherectomy specimens in humans. Am J Cardiol 2003;92:476. 38. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107:113–9. 39. Dangas G, Mintz GS, Mehran R, et al. Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. Circulation 1999;99:3149 –54. 40. Stefanadis C, Toutouzas K, Vavuranakis M, Tsiamis E, Vaina S, Toutouzas P. New balloon-thermography catheter for in vivo temperature measurements in human coronary atherosclerotic plaques: a novel approach for thermography? Catheter Cardiovasc Interv 2003;58:344 –50. 41. Schoenhagen P, Stone GW, Nissen SE, et al. Coronary plaque morphology and frequency of ulceration distant from culprit lesions in patients with unstable and stable presentation. Arterioscler Thromb Vasc Biol 2003;23:1895–900. 42. Toutouzas K, Vaina S, Tsiamis E, et al. Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins. Am Heart J 2004;148:783– 8.
